![](/img/cover-not-exists.png)
Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts
van der Helm, L.H., Veeger, N.J.G.M., Kooy, M. van Marwijk, Beeker, A., de Weerdt, O., de Groot, M., Alhan, C., Hoogendoorn, M., Laterveer, L., van de Loosdrecht, A.A., Koedam, J., Vellenga, E., Huls,Volume:
37
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/j.leukres.2013.03.022
Date:
August, 2013
File:
PDF, 605 KB
english, 2013